Press releases - Ypsomed

Ypsomed and ten23 health collaborate for the commercialization of the YpsoDose patch injector

04/16/2024 - 7:00am Press Releases Ypsomed Group

Burgdorf – Ypsomed enters a partnership with ten23 health, a global Swiss contract development and manufacturing organization. The aim of this collaboration is to advance the commercialization of the YpsoDose wearable injector for the subcutaneous self-injection of large-volume doses. ten23’s drug development, filling and device assembly expertise will significantly contribute to the product offering.

Topics:

Platforms & Operational Excellence

Ypsomed enhances self-injection device platforms with integrated human factors services

10/05/2023 - 7:00am Press Releases Ypsomed Group

Burgdorf – Ypsomed announces new Human Factors (HF) services for its pharmaceutical partners to reinforce its position as a leading developer and manufacturer of self-injection solutions. By enhancing its device platform offering with integrated end-to-end HF services, Ypsomed is championing a comprehensive service approach to combination product development that de-risks regulatory approval and expedites time-to-market for its partners. To do so, Ypsomed has entered into a strategic partnership with Interface Analysis Associates LLC (IAA), a leading HF service provider with long-standing expertise in supporting the pharmaceutical industry along the full combination product development journey.

Topics:

Platforms & Operational Excellence